MATINAS BIOPHARMA HOLDINGS I (MTNB)

US5768101058 - Common Stock

0.1789  0 (-1.43%)

After market: 0.1793 +0 (+0.22%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
1.10M3.19M33.33K158.33K89.81K
Operating Expenses
24.86M27.78M24.77M24.36M19.01M
Research and Development
14.49M16.68M14.58M14.36M11.23M
Selling, General, and Administrative Expenses
10.37M11.10M10.18M10.01M7.78M
Operating Income
-23.77M-24.59M-24.73M-24.21M-18.92M
Interest Income/Expense
N/AN/AN/A686.43K541.30K
Other Income/Expense
340.00K102.00K122.87KN/AN/A
Non Recurring Items
484.00K3.49M1.33M1.07M1.01M
Income Before Taxes
-22.94M-21.00M-23.28M-22.45M-17.37M
Income Tax
N/AN/AN/AN/A0.00
Net Income
-22.94M-21.00M-23.68M-23.24M-18.30M
EBITDA
-23.37M-24.23M-24.45M-23.92M-18.59M
 
Per Share Data
EPS Diluted Total Ops
-0.11-0.10-0.11-0.12-0.13
Non GAAP EPS
-0.11-0.11-0.11-0.12-0.14
 
Statistics
Profit Margin
-2093.25%-658.63%-71044.73%-14678.38%-20372.80%
Operating Profit Margin
-2168.43%-771.33%-74211.70%-15288.68%-21067.85%

All data in USD

Charts